<<
BACK TO EIGHTH GAVI BOARD MEETING
Eighth GAVI Board Meeting, Paris, 19-20 June 2002
3. Lessons Learned
Click
here to download presentation [Powerpoint, 57 kb]
Click
here to download paper [Word, 980 kb]
Click
here to download summary [Word, 47 kb]
Discussion
- The updated analysis of the vaccine industry and
the review of the first GAVI procurement process are important
contributions to the Alliance as we think about how to better
manage our efforts and act as an effective catalyst for improved
collaboration between the public and private sector.
- In the future, the procurement process for GAVI
and The Vaccine Fund should be based on a single line of reporting
and have much more rigorous monitoring and accountability than
the current system. It should also, over time, work to develop
much more accurate data about demand at country level. The new
system could potentially serve middle income countries as well
as Vaccine Fund eligible countries.
DECISIONS
The Board:
2.1 Agreed that an in-depth discussion of vaccine security
and the changing vaccine environment and the issues involved in
securing adequate vaccine supply from multinational and emerging
vaccine producers, and fostering cooperation between them, should
be a major topic of discussion at the Partners' meeting.
2.2 Approved the new project management structure for
the preparation and implementation of the upcoming tender process.
In the recommended structure, the project manager would be affiliated
with WHO or UNICEF Program Department and be supported by a team
made up of partners from WHO, UNICEF Program Division and Supply
Division, and the Vaccine Fund. The project manager would report
to the GAVI Board, via an oversight committee made up of a developing
country government Board member (India) and an OECD country government
(tbd), with facilitation / support from the Executive Secretary.
This oversight committee will act as a conduit between the procurement
project management team and the Board.
2.3 Endorsed the proposal from UNICEF and WHO, supported
by The Vaccine Fund, that they should move forward with the process
of recruiting a GAVI procurement project manager and assembling
a team, possibly to be housed in the Geneva office of UNICEF.
2.4 Requested that vaccine manufacturers explore how
they could engage in the procurement activity without creating conflict
of interest.
2.5 Requested manufacturers to consider a slight delay
of the 2004-06 tender process.
<<
BACK TO EIGHTH GAVI BOARD MEETING
|